Coverage
-
November 30, 2023
The federal government told a D.C. federal court that it shouldn't issue Merck & Co. Inc.'s summary judgment in its lawsuit challenging the Inflation Reduction Act's Medicare drug price negotiation program, saying its takings clause and First Amendment arguments are "dubious."
10 other articles on this case.
View all »